Clinical Trials
27 trialsRE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience Inc
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
Cancer Research UK
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
ELSA-FN
Murdoch Childrens Research Institute
A Study of LM-350 in Subjects With Advanced Solid Tumours
LaNova Medicines Limited
INJECTABL-3
Immunophotonics, Inc.
Impact of Anesthesia Maintenance Methods on 5-year Survival After Surgery
Peking University First Hospital
LUTARTERIAL
University Hospital, Bordeaux
QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer
NantBioScience, Inc.
INJECTABL-1
Immunophotonics, Inc.
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
North China Petroleum Bureau General Hospital
COSEFDIP
Xijing Hospital
Impact of Anesthesia Maintenance Methods on Long-term Survival
Peking University First Hospital
Impact of Anesthesia Maintenance Methods on Incidence of Postoperative Delirium
Peking University First Hospital
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor
Andes Biotechnologies
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Study of Sodium Bicarbonate in Restoring Blocked Catheters
University Health Network, Toronto
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors
Andes Biotechnologies
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Traws Pharma, Inc.
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Shanghai Gebaide Biotechnology Co., Ltd.
Phase I Study of LB-100 With Docetaxel in Solid Tumors
Lixte Biotechnology Holdings, Inc.
RATIOMTD
L'Hospitalet de Llobregat
Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness
Spectrum Pharmaceuticals, Inc
Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy
Danish University of Pharmaceutical Sciences
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
INSYS Therapeutics Inc